课题基金 / 基金详情

BIOTRANSFORMATION PRODUCTS OF OXALIPLATIN COLORECTAL CANCER

BIOTRANSFORMATION PRODUCTS OF OXALIPLATIN COLORECTAL CANCER
奥沙利铂结直肠癌生物转化产品
批准号：
6297277
负责人：
STEPHEN BERNARD
金额：
$0.02万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6297277
关键词：
antineoplastics biotransformation cis platinum compound clinical research colorectal neoplasms human subject human therapy evaluation neoplasm /cancer chemotherapy

项目摘要

项目成果

STEPHEN BERNARD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. To evaluate the ratio of oxaliplatin to its biotransformation product following two separate infusions in patients with advanced colorectal cancer. 2. To determine the potential for the relative contribution of oxaliplatin and its biotransformation product to the development of neurotoxicity associated with oxaliplatin treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NSABP P-1--TRIAL TO DETERMINE WORTH OF TAMOXIFEN FOR PREVENTING BREAST CANCER
MX 405: INTRADOSE (CISPLATIN & EPINEPHRINE) INJECTABLE GEL
BIOTRANSFORMATION PRODUCTS OF OXALIPLATIN COLORECTAL CANCER
BIOTRANSFORMATION PRODUCTS OF OXALIPLATIN COLORECTAL CANCER
海外基金